Results 111 to 120 of about 872 (156)

Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis. [PDF]

Front Endocrinol (Lausanne)
Ciołkiewicz M, Kuryliszyn-Moskal A, Jabłońska E, Ratajczak-Wrona W, Janica J, Samborski W, Klimiuk PA.   +6 more
europepmc   +1 more source

Case Report: Anti-TNF-α therapy-associated destructive thyroiditis and unmasking of latent amyloid A amyloidosis in rheumatoid arthritis. [PDF]

Front Immunol
Kumagai K, Okumura N, Mimura T, Yayama T, Kubo M, Imai S.   +5 more
europepmc   +1 more source

Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry. [PDF]

Arthritis Res Ther, 2023
Pappas DA, O'Brien J, Guo L, Shan Y, Baker JF, Kricorian G, Stryker S, Collier DH.   +7 more
europepmc   +1 more source

Impact of long COVID on self-reported disease activity, disability, and quality of life in individuals with inflammatory arthritis. [PDF]

Semin Arthritis Rheum
Wallace ZS, Lin M, Srivatsan S, King A, Wang X, Venkat R, Kawano Y, Negron M, Hang B, Schiff A, Hanberg J, Kowalski EN, Johnson C, Vanni KMM, Williams Z, Qian G, Bolden C, Mueller KT, Bade KJ, Saavedra AA, Patel NJ, Sparks JA.   +21 more
europepmc   +1 more source

Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis. [PDF]

Rheumatol Adv Pract
Sheppard R, Gianatsi M, Thomas I, King S, Gillespie D, Pallmann P, Barril SM, Choy E.   +7 more
europepmc   +1 more source

Exploring the Factors Related to Medication Adherence in Patients with Rheumatoid Arthritis Based on Social Cognitive Theory: A Path Analysis. [PDF]

Patient Prefer Adherence
Liang L, Zhang X, Pan Y, Huang L, Jia L, Xu P, Li K.   +6 more
europepmc   +1 more source

The Liver-Heart Axis in Rheumatoid Arthritis: Associations of Liver Fibrosis, Organokines, Endothelin-1, and Cardiovascular Risk. [PDF]

Int J Mol Sci
Ciołkiewicz M, Kuryliszyn-Moskal A, Jabłońska E, Ratajczak-Wrona W, Janica JR, Samborski W, Klimiuk PA.   +6 more
europepmc   +1 more source

慢性関節リウマチ患者の温泉治療効果に関する要因の分析

1998年4月より9月までの6ヶ月間に当院へ入院し温泉療法をうけた慢性関節リウマチ患者6例を対象に,温泉治療経験の有無,年齢,機能障害度(クラス),罹患年数の4項目が温泉療法効果に及ぼす影響につき検討した｡温泉治療経験の有無では治療経験を有する患者においてMHAQ(modified health assessment questionnaile),患者による疼痛評価,患者による全般活動性評価に有意な改善が見られ,年齢(75才以上,75才未満)では,75才未満においてMHAQに有意な改善傾向が見られた ...
中村, 寿美江, 原田, 誠之, 能見, 真由美, 谷崎, 勝朗, 田熊, 正栄, 吉尾, 慶子   +5 more
core  

Risk factors for vertebral fracture in rheumatoid arthritis patients using biological disease-modifying anti-rheumatic drugs (cases over 5 years): An observational study. [PDF]

Medicine (Baltimore)
Tokumoto H, Tominaga H, Maeda S, Sasaki H, Kawamura I, Setoguchi T, Taniguchi N.   +6 more
europepmc   +1 more source

Associations between comorbidities and patient-reported outcomes in axial spondyloarthritis: data from a single-center real-world cohort. [PDF]

Clin Rheumatol
Biedroń G, Wilk M, Nowakowski J, Kuszmiersz P, Guła Z, Strach M, Brkic A, Haugeberg G, Korkosz M.   +8 more
europepmc   +1 more source